<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Chiesi Group 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=50301></link><description><![CDATA[Chiesi Group 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Mon, 27 Apr 2026 14:40:43 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2026/03/12_1028147215_20260312081621_1270474872.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[Chiesi and Bespak Partner to Advance Carbon Minimal Inhaler Production With UK Manufacturing Site]]></title><link>https://www.newswire.co.kr/newsRead.php?no=1030127</link><description><![CDATA[PARMA, Italy & HOLMES CHAPEL, England--(Business Wire/Korea Newswire)--Chiesi Group (“Chiesi”), the international research focused biopharmaceutical company and a certified B Corp, and Bespak, the specialist inhalation CDMO focused on pulmonary and nasal drug delivery, today announced an expansion of their long-standing partnership, increasing pressurized metered dose inhaler (pMDI) manufacturing capacity at Bespak...]]></description><pubDate>Thu, 12 Mar 2026 08:36:14 +0900</pubDate></item></channel></rss>